Novel Epigenetic Targets in Lymphoproliferative Disorders
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
378-391
Author(s):
Julio Delgado
Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1802-1826
Author(s):
Yashveer Singh, Matthew Palombo and Patrick J. Sinko
Gene therapy for Multiple Myeloma
Journal:
Current Gene Therapy
Volume:
8
Page:
247-255
Author(s):
Yasuo Adachi, Naoko Yoshio-Hoshino and Norihiro Nishimoto
Cancer and Stem Cells
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
168-177
Author(s):
Lydia Gutierrez-Gonzalez, Osamu Inatomi, Julia Burkert and Nichoals A. Wright
Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
188-195
Author(s):
Lena Motoda, Motomi Osato and Yoshiaki Ito
Role of mTOR in Hematological Malignancies
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
211-218
Author(s):
Uzma Athar and Ajeet Gajra
Wnt Signaling and Prostate Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
271-580
Author(s):
Daniel R. Robinson, Cassandra R. Zylstra and Bart O. Williams
Mistletoe Lectins: Carbohydrate-Specific Apoptosis Inducers and Immunomodulators
Journal:
Current Organic Chemistry
Volume:
12
Page:
918-925
Author(s):
Daniel C. Hoessli and Ishtiaq Ahmad
The Coagulation Cascade in Sepsis
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1860-1869
Author(s):
Ling Wang, Julie A. Bastarache and Lorraine B. Ware
Novel Preparative Regimens in Hematopoietic Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1923-1935
Author(s):
Lazaros Lekakis, Leandro de Padua Silva and Marcos de Lima